Access disease-level, longitudinal, oncology patient data to inform life science research, development, and commercial strategies with Vantage.
From R&D to post marketing and HEOR, Vantage helps oncology biopharma teams identify opportunities and create enterprise level strategies for specific cancer diagnoses.
Conduct Phase IV and HEOR studies and optimize commercial strategy.
COTA’s database of patients includes longitudinal treatment and outcomes data for oncology patients including:
Explore our collection of clinical research, recent press, podcasts, and more.
Nearly 4 million women worldwide are diagnosed with breast or gynecological cancers each year. Yet too many factors around these...
Cancer comes in many forms, including hematologic malignancies that originate in blood-forming tissues or in the cells of the immune...
Since the turn of the century, there’s been a growing recognition that the health of our friends, families, & communities...
Discover the power of real-world cancer data for your life science organization.
